Access cutting-edge lymphoma treatment through this clinical trial at a research site in La Crosse. Study-provided care at no cost to qualified participants.
Access lymphoma specialists in La Crosse at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lymphoma treatment provided free
This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or does not respond to therapy (refractory), clonal cytopenia of undetermined significance and chronic myelomonocytic leukemia (CMML). Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing
Sponsor: Mayo Clinic
Check if you qualify for this lymphoma clinical trial in La Crosse, WI
If you're searching for lymphoma treatment options in La Crosse, WI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Crosse research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.